Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Alembic Pharmaceuticals Limited (Units I and II)
FDA Inspection
•Alembic Pharmaceuticals Limited (Units I and II)•October 8, 2024

Alembic Pharmaceuticals Limited (Units I and II) – FDA Inspection, Oct 8, 2024

Record Details

This FDA Inspection record concerns Alembic Pharmaceuticals Limited (Units I and II), with an inspection on October 8, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Alembic Pharmaceuticals Limited (Units I and II)
Inspection Date
October 8, 2024
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Kara A. Scheibner (Company Rep)
  • Sylvestre K. Dossou (Issuing Officer)
View Company Profile

ID · 56945324-5d2c-4de3-b337-fddb20579310

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number
1249881
FDA center
Human Drugs
Project area
Bioresearch Monitoring

Other FDA inspections of Alembic Pharmaceuticals Limited (Units I and II)

8
DateClassificationOfficeProject area
May 31, 2025Not classifiedOffice of Inspections and Investigations
December 19, 2018Not classifiedOffice of Inspections and Investigations
April 23, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 29, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 18, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Alembic Pharmaceuticals Limited (Units I and II)
  • FDA Inspection 1270216 - 2025-05-31
  • FDA Inspection 1076862 - 2018-12-19
  • FDA Inspection 1055013 - 2018-04-23
  • FDA Inspection 982077 - 2016-06-29
  • FDA Inspection 831397 - 2013-04-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alembic Pharmaceuticals Limited (Units I and II)
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.